Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2019 1
2021 2
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain).
Hernandez-Aguado JJ, Sánchez Torres DÁ, Martínez Lamela E, Aguión Gálvez G, Sanz Espinosa E, Pérez Quintanilla A, Martínez-Carrillo DA, Ramírez Mena M, Coronado Martín PJ, Zapardiel I, de la Fuente-Valero J. Hernandez-Aguado JJ, et al. Vaccines (Basel). 2022 Mar 3;10(3):387. doi: 10.3390/vaccines10030387. Vaccines (Basel). 2022. PMID: 35335019 Free PMC article.
Substance use, mental health and dual disorders on pregnancy: Results of prevalence and treatment rates in a developed country.
Carmona Camacho R, López Carpintero N, Barrigón ML, Ruiz Nogales C, Menéndez I, Sánchez Alonso M, Caro Cañizares I, Hernández Aguado JJ, Le Cook B, Alegría M, Saviron Cornudella R, Plaza J, Baca-García E. Carmona Camacho R, et al. Adicciones. 2022 Nov 29;34(4):299-308. doi: 10.20882/adicciones.1568. Adicciones. 2022. PMID: 33768264 Free article. English, Spanish.
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study.
Joura EA, Ulied A, Vandermeulen C, Rua Figueroa M, Seppä I, Hernandez Aguado JJ, Ahonen A, Reich O, Virta M, Perino A, Peris Tuser M, Peters K, Origoni M, Raspagliesi F, Tjalma WAA, Tummers P, Woelber L, Nieminen P, van Damme P, Sehouli J, Fiol Ruiz G, Brucker S, Fehm T, Cheon K, Rawat S, Luxembourg A, Wittke F. Joura EA, et al. Vaccine. 2021 May 12;39(20):2800-2809. doi: 10.1016/j.vaccine.2021.01.074. Epub 2021 Mar 3. Vaccine. 2021. PMID: 33676783 Clinical Trial.
Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study.
Casajuana-Pérez A, Ramírez-Mena M, Ruipérez-Pacheco E, Gil-Prados I, García-Santos J, Bellón-Del Amo M, Hernández-Aguado JJ, de la Fuente-Valero J, Zapardiel I, Coronado-Martín PJ. Casajuana-Pérez A, et al. Among authors: hernandez aguado jj. Vaccines (Basel). 2022 Feb 14;10(2):288. doi: 10.3390/vaccines10020288. Vaccines (Basel). 2022. PMID: 35214747 Free PMC article.
Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study.
Hernández-Aguado JJ, de La Fuente-Valero J, Ramírez Mena M, Ortega-Medina L, Vidart Aragón JA, Galán JC. Hernández-Aguado JJ, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 May;41(5):262-268. doi: 10.1016/j.eimce.2022.08.001. Epub 2022 Aug 10. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 35963773 Free article.
Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study.
Hernández-Aguado JJ, de La Fuente-Valero J, Ramírez Mena M, Ortega-Medina L, Vidart Aragón JA, Galán JC. Hernández-Aguado JJ, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug 14:S0213-005X(21)00231-7. doi: 10.1016/j.eimc.2021.07.010. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34404547 Free article. English, Spanish.
11 results